The estimated Net Worth of Terrance J Coughlin is at least 4.11 百万$ dollars as of 21 February 2020. Mr. Coughlin owns over 108,968 units of Endo International plc stock worth over 90,289$ and over the last 8 years he sold ENDP stock worth over 0$. In addition, he makes 4,018,300$ as Chief Operating Officer、 Executive Vice President at Endo International plc.
Terrance has made over 2 trades of the Endo International plc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 108,968 units of ENDP stock worth 31,884$ on 21 February 2020.
The largest trade he's ever made was exercising 108,968 units of Endo International plc stock on 21 February 2020 worth over 31,884$. On average, Terrance trades about 6,788 units every 49 days since 2017. As of 21 February 2020 he still owns at least 308,574 units of Endo International plc stock.
You can see the complete history of Mr. Coughlin stock trades at the bottom of the page.
Terrance John Coughlin is Chief Operating Officer, Executive Vice President of the Company. In this role, Mr. Coughlin has responsibility for Manufacturing and Technical Operations and R&D across the enterprise. Most recently, Mr. Coughlin served as Vice President, Operations of Par Pharmaceutical Companies, Inc., a subsidiary of Endo. Prior to Endo’s acquisition of Par in September 2015, Mr. Coughlin was the Chief Operating Officer of Par Pharmaceutical Companies, Inc. Prior to joining Par, Mr. Coughlin held numerous leadership roles with Glenmark Generics, Inc. USA/Glenmark Generics Limited, most recently having served as the President and Chief Executive Officer of Glenmark Generics, Inc. USA/Glenmark Generics Limited. Prior to this, Mr. Coughlin had the overall responsibility for Glenmark’s North American, Western European and Eastern European generics businesses, as well as its global active pharmaceutical ingredient business and generics operations in India. Prior to joining Glenmark, Mr. Coughlin served as Senior Vice President at Dr. Reddy’s Laboratories, Inc. Mr. Coughlin began his career in 1988 with Wyckoff Chemical Company, Inc. Mr. Coughlin earned a B.S. in chemistry from Central Michigan University.
As the Chief Operating Officer、 Executive Vice President of Endo International plc, the total compensation of Terrance Coughlin at Endo International plc is 4,018,300$. There are 1 executives at Endo International plc getting paid more, with Paul Campanelli having the highest compensation of 13,118,300$.
Terrance Coughlin is 55, he's been the Chief Operating Officer、 Executive Vice President of Endo International plc since 2016. There are 7 older and 9 younger executives at Endo International plc. The oldest executive at Endo International plc is Michael Hyatt, 74, who is the Independent Director.
Terrance's mailing address filed with the SEC is C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN, L2, .
Over the last 11 years, insiders at Endo International plc have traded over 3,455,441$ worth of Endo International plc stock and bought 152,347 units worth 3,901,804$ . The most active insiders traders include Silva Rajiv De、Paul Campanelli、Shane Cooke. On average, Endo International plc executives and independent directors trade stock every 36 days with the average trade being worth of 12,163$. The most recent stock trade was executed by Patrick A Barry on 29 March 2022, trading 59,298 units of ENDP stock currently worth 17,351$.
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.
Endo International plc executives and other stock owners filed with the SEC include: